- Report
- October 2026
- 207 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 204 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 177 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 216 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 204 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 477 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 277 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 104 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 140 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 139 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 154 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 136 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 118 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 373 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 181 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 197 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 221 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 285 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 134 Pages
Global
From €5388EUR$5,850USD£4,554GBP
- Report
- October 2026
- 121 Pages
Global
From €5388EUR$5,850USD£4,554GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more